IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 28 filers reported holding IMMUCELL CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $175,453 | +6.8% | 32,857 | 0.0% | 0.04% | +5.1% |
| Q2 2023 | $164,285 | -2.2% | 32,857 | 0.0% | 0.04% | -11.4% |
| Q1 2023 | $167,899 | -22.5% | 32,857 | -7.5% | 0.04% | -30.2% |
| Q4 2022 | $216,745 | -18.5% | 35,532 | 0.0% | 0.06% | -17.1% |
| Q3 2022 | $266,000 | -13.9% | 35,532 | 0.0% | 0.08% | -14.6% |
| Q2 2022 | $309,000 | -30.2% | 35,532 | -22.5% | 0.09% | -9.2% |
| Q1 2022 | $443,000 | -26.7% | 45,876 | -39.2% | 0.10% | -19.7% |
| Q4 2021 | $604,000 | -21.5% | 75,469 | -8.1% | 0.12% | -26.9% |
| Q3 2021 | $769,000 | -7.2% | 82,125 | -5.8% | 0.17% | -3.5% |
| Q2 2021 | $829,000 | -1.7% | 87,225 | -0.2% | 0.17% | -7.5% |
| Q1 2021 | $843,000 | +60.9% | 87,425 | -0.7% | 0.19% | +46.1% |
| Q4 2020 | $524,000 | +9.6% | 88,025 | 0.0% | 0.13% | +16.4% |
| Q3 2020 | $478,000 | +14.9% | 88,025 | 0.0% | 0.11% | +1.9% |
| Q2 2020 | $416,000 | – | 88,025 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Financial Services, Inc. | 23,776 | $89,000 | 0.03% |
| SHUFRO ROSE & CO LLC | 51,263 | $192,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 254 | $1,000 | 0.00% |
| Creative Planning | 310 | $1,000 | 0.00% |
| Renaissance Technologies | 10,000 | $38,000 | 0.00% |
| UBS AG | 1,870 | $7,000 | 0.00% |
| US BANCORP \DE\ | 24 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,032 | $8,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1 | $0 | 0.00% |
| MORGAN STANLEY | 29,628 | $111,000 | 0.00% |